Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: A matched case-control study

Intensive Care Medicine

Volumn 33, Issue 7, 2007, Pages 1162-1167

  Kallel, H ^a   Hergafi, L ^a   Bahloul, M ^a   Hakim, A ^b   Dammak, H ^a   Chelly, H ^a   Hamida, C Ben ^a   Chaari, A ^a   Rekik, N ^a   Bouaziz, M ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Colistin; Imipenem; Nephrotoxicity; Ventilator associated pneumonia

Indexed keywords

COLISTIN; IMIPENEM;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; IMIPENEM; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 34447130382     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0675-2     Document Type: Article

References (26)

1. Jones RN (2001) Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 119:397S-404S
2. Flournoy DJ, Reinert RL, Bell-Dixon C, Gentry CA (2000) Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units. Am J Infect Control 28:244-250
3. Reina R, Estenssoro E, Saenz G, Canales HS, Gonzalvo R, Vidal G, Martins G, Das Neves A, Santander O, Ramos C (2005) Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31:1058-1065
4. Falagas ME, Kasiakou SK (2006) Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10:R27
5. Olesen S, Madsen PO (1967) Intravenous administration of sodium colistimethate in urinary tract infections. Curr Ther Res Clin Exp 9:283-287
6. Price DJ, Graham DI (1970) Effects of large doses of colistin sulphomethate sodium on renal function. Br Med J 4:525-527
7. Tripathi VN, Stulberger EA, Takacs FJ (1970) Colistimethate overdosage. J Urol 104:176-178
8. Devlieger H, Casteels-Van Daele M, Ki MB, Proesmans W (1977) Acute renal failure due to colistin intoxication. Acta Paediatr Belg 30:179-181
9. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanii. Clin Infect Dis 28:1008-1011
10. Jimenez-Mejias ME, Becerril B, Marquez-Rivas FJ, Pichardo C, Cuberos L, Pachon J (2000) Successful treatment of multidrug-resistant Acinetobacter baumanii meningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Infect Dis 19:970-971
11. Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J (2002) Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumanii meningitis. Eur J Clin Microbiol Infect Dis 21:212-214
12. Stein A, Raoult D (2002) Colistin: an antimicrobial for the 21st century? Clin Infect Dis 35:901-902
13. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L (2003) Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7:R78-83
14. Ouderkirk JP, Nord JA, Turett GS, Kislak JW (2003) Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria. Antimicrob Agents Chemother 47:2659-2662
15. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D (2003) Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 37:e154-160
16. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-WittelI M, Gallego-Lara SL, Madrazo-Osuna J (2003) Treatment of multidrug-resistant Acinetobacter baumanii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36:1111-1118
17. Karabinis A, Paramythiotou E, Mylona-Petropoulou D, Kalogeromitros A, Katsarelis N, Kontopidou F, Poularas I, Malamou-Lada H (2004) Colistin for Klebsiella pneumonia-associated sepsis. Clin Infect Dis 38:e7-9
18. Falagas ME, Fragoulis KN, Kasiakou SK, Sermaidis GJ, Michalopoulos A (2005) Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents 26:504-507
19. Reina R, Estenssoro E, Saenz G, Canales HS, Gonzalvo R, Vidal G, Martins G, Das Neves A, Santander O, Ramos C (2005) Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31:1058-1065
20. Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W, Chelly H, Hamida CB, Rekik N, Hammami A, Bouaziz M (2006) Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents. 28:366-369
21. Kallel H, Bahloul M, Ksibi H, Dammak H, Chelly H, Hamida CB, Chaari A, Rekik N, Bouaziz M (2005) Prevalence of hospital-acquired infection in a Tunisian hospital. J Hosp Infect 59:343-347
22. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
23. Marquette CH, Georges H, Wallet F, Ramon P, Saulnier F, Neviere R, Mathieu D, Rime A, Tonnel AB (1993) Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis 148:138-144
24. Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371-1375
25. Anon (2000) Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standards document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA, USA
26. Anon (2000) Performance standard for antimicrobial susceptibility testing. Document M100-S10. National Committee for Clinical Laboratory Standards, Wayne, PA, USA